UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ovarian cancer statistics, 2018

CA: a cancer journal for clinicians, 2018-07, Vol.68 (4), p.284-296

2018

Volltextzugriff (PDF)

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Journal of clinical oncology, 2016-02, Vol.34 (6), p.611-635

2016

Volltextzugriff (PDF)

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

CA: a cancer journal for clinicians, 2016-01, Vol.66 (1), p.43-73

2016

Volltextzugriff (PDF)

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1553-1561

2012

Volltextzugriff (PDF)

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI : Journal of the National Cancer Institute, 2005-11, Vol.97 (22), p.1652-1662

2005

Volltextzugriff (PDF)

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Cancer prevention research (Philadelphia, Pa.), 2010-06, Vol.3 (6), p.696-706

2010

Volltextzugriff (PDF)

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)

American journal of obstetrics and gynecology, 2011-12, Vol.205 (6), p.535.e1-535.e5

2011

Volltextzugriff (PDF)

Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III

Gynecologic oncology, 2007-09, Vol.106 (3), p.453-460

2007

Volltextzugriff (PDF)

Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity

Obstetrics and gynecology (New York. 1953), 2021-03, Vol.137 (3), p.423-429

2021

Volltextzugriff (PDF)

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment

Gynecologic oncology, 2010-12, Vol.119 (3), p.451-456

2010

Volltextzugriff (PDF)

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update

Journal of clinical oncology, 2019-11, Vol.37 (33), p.JCO1901472-3165

2019

Volltextzugriff (PDF)

Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

Journal of clinical oncology, 2021-06, Vol.39 (18), p.JCO2100471-2048

2021

Volltextzugriff (PDF)

Association of tamoxifen and uterine sarcoma

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2758-2760

2002

Volltextzugriff (PDF)

Florida International University Herbert Wertheim College of Medicine

Academic medicine, 2020-09, Vol.95 (9S A Snapshot of Medical Student Education in the United States and Canada: Reports From 145 Schools), p.S103-S106

2020

Volltextzugriff (PDF)

Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial

American journal of obstetrics and gynecology, 2005-04, Vol.192 (4), p.1230-1237

2005

Volltextzugriff (PDF)

Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia

Clinical cancer research, 2005-06, Vol.11 (12), p.4460-4468

2005

Volltextzugriff (PDF)

GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma

Modern pathology, 2006-11, Vol.19 (11), p.1429-1436

2006

Volltextzugriff (PDF)

Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials

Journal of clinical oncology, 2024-10, Vol.42 (30), p.3537-3549

2024

Volltextzugriff (PDF)

Chemotherapy in Pregnancy

Clinical obstetrics and gynecology, 2011-12, Vol.54 (4), p.602-618

2011

Volltextzugriff (PDF)

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

JAMA : the journal of the American Medical Association, 2006-06, Vol.295 (23), p.2727

2006

Volltextzugriff (PDF)

American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

CA: a cancer journal for clinicians, 2002-11, Vol.52 (6), p.342-362

2002

Volltextzugriff (PDF)

Molecular Screening for Cervical Cancer — Time to Give up Pap Tests?

The New England journal of medicine, 2007-10, Vol.357 (16), p.1650-1653

Runowicz, Carolyn D

2007

Volltextzugriff (PDF)

A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015

Cancer, 2006-07, Vol.107 (2), p.396-405

2006

Volltextzugriff (PDF)

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study

Gynecologic oncology, 2010-03, Vol.116 (3), p.442-446

2010

Volltextzugriff (PDF)

The Impact of the Privacy Rule on Cancer Research: Variations in Attitudes and Application of Regulatory Standards

Journal of clinical oncology, 2009-08, Vol.27 (24), p.4014-4020

2009

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Englisch
(169)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gynecologic Oncology
(32)
Cancer
(17)
Journal Of Clinical Oncology
(15)
Health News
(12)
Ca: A Cancer Journal For Clinicians
(11)
Obstetrics And Gynecology
(9)
Ca
(8)
American Journal Of Obstetrics And Gynecology
(7)
Clinical Cancer Research
(6)
Cancer Investigation
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ovarian cancer statistics, 2018

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)

Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III

Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update

Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

Association of tamoxifen and uterine sarcoma

Florida International University Herbert Wertheim College of Medicine

Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial

Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia

GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma

Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials

Chemotherapy in Pregnancy

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

Molecular Screening for Cervical Cancer — Time to Give up Pap Tests?

A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study

The Impact of the Privacy Rule on Cancer Research: Variations in Attitudes and Application of Regulatory Standards

Suchergebnisse filtern